Minerva Neurosciences sets 2026 annual meeting date
Minerva Neurosciences, Inc. set the expected date for its 2026 annual meeting of stockholders for June 3, 2026, earlier than the one-year anniversary of its 2025 meeting.
Rhea-AI Filing Summary
Minerva Neurosciences, Inc. set the expected date for its 2026 annual meeting of stockholders for June 3, 2026, earlier than the one-year anniversary of its 2025 meeting.
Because of this earlier date, stockholders who wish to bring business before the meeting or nominate directors must deliver notice to the company’s Burlington, Massachusetts headquarters by the close of business on April 21, 2026. Stockholder proposals seeking inclusion in the proxy statement under Rule 14a-8 must arrive by the close of business on April 16, 2026 and comply with the company’s bylaws and Exchange Act rules.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
2026 annual meeting date: June 3, 2026
Deadline for stockholder business and nominations: April 21, 2026
Rule 14a-8 proposal deadline: April 16, 2026
+1 more
4 metrics
2026 annual meeting date
June 3, 2026
Expected date of Minerva Neurosciences’ 2026 stockholder meeting
Deadline for stockholder business and nominations
April 21, 2026
Close of business cutoff for 2026 annual meeting notices
Rule 14a-8 proposal deadline
April 16, 2026
Cutoff for inclusion in 2026 proxy statement
Company address
1500 District Avenue, Burlington, MA 01803
Principal executive offices and mailing address for notices
Key Terms
annual meeting of stockholders, amended and restated bylaws, Rule 14a-8, proxy statement, +1 more
5 terms
annual meeting of stockholders financial
"the expected date for the Company’s 2026 annual meeting of stockholders"
amended and restated bylaws regulatory
"in accordance with the Company’s amended and restated bylaws"
A company’s amended and restated bylaws are its internal rulebook rewritten to include all changes in one updated document, replacing the old bylaws. For investors, this matters because the bylaws set how the board, shareholders and officers make decisions, hold votes and handle disputes; a new consolidated version can change voting rights, control mechanisms or procedures that affect corporate governance and the value or risk of an investment.
Rule 14a-8 regulatory
"Stockholder proposals intended for inclusion in the Company’s proxy statement ... pursuant to Rule 14a-8"
Rule 14a-8 is a U.S. Securities and Exchange Commission regulation that lets eligible shareholders put proposals on a public company’s proxy ballot for an annual meeting, provided they meet basic ownership and filing requirements. It matters to investors because it creates a formal way to raise governance or strategic issues and force a company-wide vote—like getting an item onto the agenda of a neighborhood association meeting once you’ve lived there long enough—so shareholders can push for change or influence management decisions.
proxy statement financial
"Stockholder proposals intended for inclusion in the Company’s proxy statement for the Annual Meeting"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
Exchange Act regulatory
"rules and regulations promulgated under the Exchange Act and other applicable law"
A federal law that sets rules for trading securities on public exchanges, requiring companies and market participants to register, disclose regular financial information, and follow standards that promote honest, orderly markets. For investors, it matters because it creates transparency and legal protections—like stopping insider trading and ensuring timely company disclosures—so you can evaluate risks and rely on consistent rules much as players rely on a referee to keep a game fair.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Minerva Neurosciences (NERV) hold its 2026 annual meeting?
Minerva Neurosciences expects to hold its 2026 annual meeting of stockholders on June 3, 2026. This date is more than 30 days before the one-year anniversary of the 2025 annual meeting, triggering adjusted deadlines for stockholder proposals and director nominations.
What is the deadline for Minerva Neurosciences (NERV) stockholders to submit business or director nominations for the 2026 meeting?
Stockholders must notify Minerva Neurosciences of any business to be brought before the 2026 annual meeting or any director nominations by the close of business on April 21, 2026. Notices must be delivered to the company’s principal executive offices and comply with its bylaws.
What is the Rule 14a-8 proposal deadline for Minerva Neurosciences (NERV) 2026 proxy statement?
Stockholder proposals for inclusion in Minerva Neurosciences’ 2026 proxy statement under Rule 14a-8 must be received by the close of business on April 16, 2026. The company states this is a reasonable time before it expects to begin printing and mailing proxy materials for the meeting.
Where should Minerva Neurosciences (NERV) stockholders send notices and proposals for the 2026 annual meeting?
Stockholder notices and proposals must be directed to Minerva Neurosciences, Inc., Attention: Secretary, 1500 District Avenue, Burlington, Massachusetts 01803. Submissions must also meet the requirements of the company’s amended and restated bylaws, Exchange Act rules, and other applicable law.
Why did Minerva Neurosciences (NERV) update deadlines for the 2026 annual meeting?
The company set its 2026 annual meeting for June 3, 2026, more than 30 days before the one-year anniversary of the 2025 meeting. This earlier timing, under its bylaws, requires specific new cutoff dates for stockholder business, director nominations, and Rule 14a-8 proposals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
